Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 51, 2010, Pages 22272-22277

  Banks, William A ^a,b   Morley, John E ^c,d   Farr, Susan A ^c,d   Price, Tulin O ^c,d   Ercal, Nuran ^e   Vidaurreg, Irving ^f   Schally, Andrew V ^f,g  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Learning; Memory; Peptide; Sarcopenia

Indexed keywords

MZ 5 156; SOMATOMEDIN C; TELOMERASE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER INCIDENCE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEEDING; LIFE EXPECTANCY; LONGEVITY; MALE; MOUSE; MUSCLE STRENGTH; NONHUMAN; ORGAN WEIGHT; OXIDATIVE STRESS; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; BRAIN; COGNITION; COGNITION DISORDERS; GROWTH HORMONE-RELEASING HORMONE; LARON SYNDROME; LONGEVITY; MICE; OXIDATIVE STRESS; SERMORELIN; TELOMERASE;

MUS;

EID: 78650642919     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1016369107     Document Type: Article

References (38)

1. Lieberman SA, Hoffman AR (1997) The somatopause: Should growth hormone deficiency in older people be treated? Clin Geriatr Med 13:671-684.
2. Laron Z (2005) Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity? Mech Ageing Dev 126:305-307.
3. Liu H, et al. (2007) Systematic review: The safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 146:104-115.
4. Dominguez LJ, Barbagallo M, Morley JE (2009) Anti-aging medicine: Pitfalls and hopes. Aging Male 12:13-20.
5. Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119:3189-3202.
6. Bartke A (2003) Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 78:210-216.
7. Chandrashekar V, et al. (2007) Age-related alterations in pituitary and testicular functions in long-lived growth hormone receptor gene-disrupted mice. Endocrinology 148:6019-6025.
8. Schaible R, Gower JW (1961) A new dwarf mouse. Genetics 46:896.
9. Sornson MW, et al. (1996) Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384:327-333.
10. Coschigano KT, Clemmons D, Bellush LL, Kopchick JJ (2000) Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141:2608-2613.
11. Holzenberger M, et al. (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421:182-187.
12. Schally AV, Varga JL, Engel JB (2008) Antagonists of growth-hormone- releasing hormone: An emerging newtherapyfor cancer. Nat Clin Pract Endocrinol Metab 4:33-43.
13. Barabutis N, Schally AV (2008) Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line. Proc Natl Acad Sci USA 105:20470-20475.
14. Morley JE, Farr SA, Flood JF (2002) Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice. Neurobiol Learn Mem 78:125-138.
15. Wege H, Chui MS, Le HT, Tran JM, Zern MA (2003) SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Nucleic Acids Res 31:E3.
16. Lança V, Zee RY, Rivera A, Romero JR (2009) Quantitative telomerase activity in circulating human leukocytes: Utility of real-time telomeric repeats amplification protocol (RQ-TRAP) in a clinical/epidemiological setting. Clin Chem Lab Med 47:870-873.
17. Kovacs M, et al. (1997) Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly. Endocrinology 138:4536-4542.
18. Kovács M, Schally AV, Zarándi M, Groot K (1997) Inhibition of GH release of rats by new potentant agonists of growth hormone-releasing hormone (GH-RH). Peptides 18:431-438.
19. Hammond RS, Tull LE, Stackman RW (2004) On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem 82:26-34.
20. de Lima MN, Luft T, Roesler R, Schröder N (2006) Temporary inactivation reveals an essential role of the dorsal hippocampus in consolidation of object recognition memory. Neurosci Lett 405:142-146.
21. Poon HF, et al. (2005) Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: Implications for aging and age-related neurodegenerative disorders. Neurochem Int 46:159-168.
22. Poon HF, et al. (2004) Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res 1018:86-96.
23. Farr SA, et al. (2003) The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 84: 1173-1183.
24. Kumar VB, et al. (2000) Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides 21:1769-1775.
25. Morley JE (1997) Anorexia of aging: Physiologic and pathologic. Am J Clin Nutr 66: 760-773.
26. Morley JE (2001) Decreased food intake with aging. J Gerontol A Biol Sci Med Sci 56 (Spec No 2):81-88.
27. Schwob AE, Nguyen LJ, Meiri KF (2008) Immortalization of neural precursors when telomerase is overexpressed in embryonal carcinomas and stem cells. Mol Biol Cell 19:1548-1560.
28. Blackburn EH (1991) Structure and function of telomeres. Nature 350:569-573.
29. Cunningham AP, Love WK, Zhang RW, Andrews LG, Tollefsbol TO (2006) Telomerase inhibition in cancer therapeutics: Molecular-based approaches. Curr Med Chem 13:2875-2888.
30. Herbert BS, Hochreiter AE, Wright WE, Shay JW (2006) Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol. Nat Protoc 1: 1583-1590.
31. Kiaris H, Schally AV (1999) Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone. Proc Natl Acad Sci USA 96:226-231.
32. Farr SA, Flood JF, Morley JE (2000) The effect of cholinergic, GABAergic, serotonergic, and glutamatergic receptor modulation on posttrial memory processing in the hippocampus. Neurobiol Learn Mem 73:150-167.
33. Jaeger LB, Farr SA, Banks WA, Morley JE (2002) Effects of orexin-A on memory processing. Peptides 23:1683-1688.
34. Winters RA, Zukowski J, Ercal N, Matthews RH, Spitz DR (1995) Analysis of glutathione, glutathione disulfide, cysteine, homocysteine, and other biological thiols by high-performance liquid chromatography following derivatization by n-(1-pyrenyl)maleimide. Anal Biochem 227:14-21.
35. Ridnour LA, Winters RA, Ercal N, Spitz DR (1999) Measurement of glutathione, glutathione disulfide, and other thiols in mammalian cell and tissue homogenates using high-performance liquid chromatography separation of N-(1-pyrenyl)maleimide derivatives. Methods Enzymol 299:258-267.
36. Draper HH, et al. (1993) A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 15:353-363.
37. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
38. Kim NW, Wu F, Wu F (1997) Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 25:2595-2597.